Gladius Capital Management LP Collegium Pharmaceutical, Inc Transaction History
Gladius Capital Management LP
- $166 Million
- Q3 2024
A detailed history of Gladius Capital Management LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Gladius Capital Management LP holds 830 shares of COLL stock, worth $27,049. This represents 0.02% of its overall portfolio holdings.
Number of Shares
830
Previous 830
-0.0%
Holding current value
$27,049
Previous $32,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding COLL
# of Institutions
249Shares Held
36.2MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$189 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.9 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$76.5 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$69.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$54 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.11B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...